Afya (NASDAQ:AFYA) Sees Large Volume Increase After Analyst Upgrade

Afya Limited (NASDAQ:AFYA) shares saw unusually-strong trading volume on Wednesday after JPMorgan Chase & Co. upgraded the stock from a neutral rating to an overweight rating. JPMorgan Chase & Co. now has a $19.00 price target on the stock, down from their previous price target of $21.00. Approximately 152,529 shares changed hands during trading, an increase of 2% from the previous session’s volume of 149,674 shares. The stock last traded at $13.8610 and had previously closed at $13.91.

Other equities analysts also recently issued research reports about the company. Wall Street Zen upgraded Afya from a “hold” rating to a “buy” rating in a research report on Saturday, September 5th. Zacks Research upgraded Afya from a “strong sell” rating to a “hold” rating in a research report on Monday. Weiss Ratings cut Afya from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, July 31st. Bradesco Corretora upgraded shares of Afya to an “outperform” rating and set a $17.00 target price on the stock in a research note on Thursday, September 24th. Finally, Bank of America reaffirmed a “neutral” rating on shares of Afya in a report on Thursday, June 11th. Two investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $17.25.

Insider Buying and Selling at Afya

In related news, insider Santos Welder Ferreira sold 4,161 shares of Afya stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $13.30, for a total value of $55,341.30. Following the completion of the transaction, the insider directly owned 35,000 shares of the company’s stock, valued at $465,500. The trade was a 10.63% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Afya News Summary

Here are the key news stories impacting Afya this week:

• Positive Sentiment: JPMorgan upgraded Afya (AFYA) from “Neutral” to “Overweight,” citing a more favorable outlook and setting a $19 price target. Although the target was lowered from $21, it still implies substantial potential appreciation from recent trading levels. JPMorgan upgrades Afya to Overweight
• Positive Sentiment: Zacks Research raised Afya’s rating from “Strong Sell” to “Hold.” While not a bullish recommendation, the change removes a notably negative rating overhang and may support investor confidence.
• Positive Sentiment: Afya shares recently gained 4.5% to $13.91, with the company’s low valuation potentially attracting value-oriented investors. The stock trades at approximately 8.5 times earnings, while its latest quarterly EPS of $0.43 exceeded the $0.40 consensus estimate.
• Neutral Sentiment: Despite JPMorgan’s upgrade, broader analyst sentiment remains cautious. Afya has an average rating of “Hold” and an average price target of $17.75, indicating upside but limited consensus conviction.
• Negative Sentiment: Insider Santos Welder Ferreira sold 4,161 shares for approximately $55,341, reducing his position by 10.63% to 35,000 shares. The transaction is relatively small but may be viewed as a modest negative signal by investors. Afya insider share sale

Hedge Funds Weigh In On Afya

Institutional investors have recently modified their holdings of the stock. Public Employees Retirement System of Ohio bought a new stake in shares of Afya during the second quarter valued at approximately $67,000. Engineers Gate Manager LP bought a new position in Afya in the 2nd quarter worth approximately $325,000. Finally, Banco BTG Pactual S.A. acquired a new position in Afya during the 4th quarter worth $462,000. 88.02% of the stock is owned by institutional investors.

Afya Stock Performance

The stock has a market cap of $1.30 billion, a price-to-earnings ratio of 8.45, a P/E/G ratio of 1.49 and a beta of 0.34. The company has a current ratio of 2.20, a quick ratio of 2.20 and a debt-to-equity ratio of 0.39. The firm has a fifty day simple moving average of $13.78 and a 200-day simple moving average of $14.26.

Afya (NASDAQ:AFYA) last released its earnings results on Friday, August 14th. The company reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.03. Afya had a return on equity of 17.58% and a net margin of 20.55%.The company had revenue of $187.80 million during the quarter, compared to the consensus estimate of $189.62 million. Analysts forecast that Afya Limited will post 1.86 EPS for the current fiscal year.

About Afya

Afya Limited (NASDAQ: AFYA) is a Brazil-based medical education and health technology company. The company provides education and professional development for physicians and other healthcare professionals, with activities spanning undergraduate medical programs, medical residency preparation, specialization courses, continuing medical education and digital learning services.

Afya also develops technology-enabled products designed to support healthcare professionals throughout their careers.